The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

It is easy to assume that the prostate is healthy when there is no usual discomfort during urination. However, prostate ...

Proteins present in men’s blood could give clues to prostate cancer risk years before diagnosis. View on euronews ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Improvements in the PSA screening process make it worth another look.

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests ‘can lead to men being over-tested’, experts say Prostate cancer blood tests can lead to men being ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

Learn about the spit test that has shown promising results for detecting prostate cancer risk, proving to be more reliable than common blood tests. Prostate cancer is one of the primary health scares ...

– ArteraAI, a leader in artificial intelligence (AI)-powered cancer tests, today announced a significant achievement – the inclusion of their ArteraAI Prostate Test in the NCCN Clinical Practice ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

Nanostics and OncoHelix have teamed up to provide Nanostics' prostate cancer blood test ClarityDX Prostate to healthcare providers and men in the Middle East. Under the deal, OncoHelix will offer the ...

An optimized SNEDDS formulation of flutamide achieved rapid self-emulsification, near-complete drug release, and stronger ...